{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:51:13Z","timestamp":1776329473722,"version":"3.50.1"},"reference-count":0,"publisher":"Universidad Nacional de C\u00f3rdoba","issue":"3","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Fac Cien Med Univ Nac Cordoba"],"abstract":"<jats:p>Hepatic transplantation (HT) is the standard of care of end-stage liver disease with Cirrhotic Cardiomyopathy (CCM), but medical treatment with combination of diuretics and non-selective beta blockers are important before and after that. Owing to its particular pathophysiology unlike another etiologies of heart failure, in CCM angiotensin-converting enzyme inhibitors (ACEI), angiotensin II type I receptor blockers (ARB), and angiotensin receptor neprilysin inhibitor (ARNI) are not recommended. Transjugular intrahepatic porto-systemic shunt (TIPS) has indications in CMM but its potential benefits and risks must be considered and more researh is necessary. HT is a demanding therapy but the most effective one, and showed improvement in QTc, diastolic and systolic dysfunction; in recent decades, in spite of more severe ill patients (more severe MELD score), survival has improved significantly due to better surgical techniques, intensive care, immunosupresive drugs, and images.<\/jats:p>","DOI":"10.31053\/1853.0605.v81.n3.44420","type":"journal-article","created":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T00:15:33Z","timestamp":1727568933000},"page":"608-626","source":"Crossref","is-referenced-by-count":0,"title":["Cardiomiopat\u00eda cirr\u00f3tica \u2013 \u00bfRealidad cl\u00ednica o simple curiosidad acad\u00e9mica? Revisi\u00f3n.","Cirrhotic cardiomyopathy \u2013 Clinically fact or academic curiosity? Review.","Cardiomiopatia cirr\u00f3tica - \u00bfRealidade cl\u00ednica ou simples curiosidades acad\u00eamicas? Revis\u00e3o."],"prefix":"10.31053","volume":"81","author":[{"given":"Hugo","family":"Ramos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"12333","published-online":{"date-parts":[[2024,9,27]]},"container-title":["Revista de la Facultad de Ciencias M\u00e9dicas de C\u00f3rdoba"],"original-title":[],"link":[{"URL":"http:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/download\/44420\/46577","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/download\/44420\/46743","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/download\/44420\/46743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T19:28:41Z","timestamp":1766431721000},"score":1,"resource":{"primary":{"URL":"http:\/\/revistas.unc.edu.ar\/index.php\/med\/article\/view\/44420"}},"subtitle":["Parte 3: tratamiento","Part 3: treatment","Parte 3: tratamento"],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9,27]]}},"URL":"https:\/\/doi.org\/10.31053\/1853.0605.v81.n3.44420","relation":{},"ISSN":["1853-0605","0014-6722"],"issn-type":[{"value":"1853-0605","type":"electronic"},{"value":"0014-6722","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,27]]}}}